NASDAQ:VECT
VectivBio
- Stock
Last Close
16.85
07/07 19:59
Market Cap
1.06B
Beta: 0.05
Volume Today
127.65K
Avg: 38.14K
PE Ratio
−7.94
PFCF: −18.81
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 1.73M - | 6.36M 268.46% | 9.04M 42.27% | 5.20M 42.50% | ||
average receivables | 295.50K - | 607.50K 105.58% | 870K 43.21% | 1.10M 26.84% | ||
book value per share | 0.96 - | 3.36 248.07% | 4.30 28.14% | 4.84 12.37% | ||
capex per share | -0.01 - | -0.01 66.07% | -0.00 78.17% | -0.00 20.69% | ||
capex to depreciation | -0.37 - | -0.34 6.51% | -0.19 45.38% | -0.31 64.59% | ||
capex to operating cash flow | 0.00 - | 0.00 35.26% | 0.00 67.53% | 0.00 66.47% | ||
capex to revenue | -0.00 - | |||||
cash per share | 2.07 - | 4.19 102.65% | 3.81 8.96% | 5.02 31.70% | ||
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | 19.09 - | |||||
debt to assets | 0.46 - | 0.00 99.64% | 0.00 30.10% | 0.04 1,836.56% | ||
debt to equity | 2.16 - | 0.00 99.83% | 0.00 30.04% | 0.05 1,847.86% | ||
dividend yield | ||||||
earnings yield | -0.14 - | -0.37 157.09% | -0.66 77.33% | -0.25 62.71% | ||
enterprise value | -2.13M - | 163.37M 7,784.24% | 123.14M 24.62% | 29.95M 75.68% | 171.40M 472.39% | |
enterprise value over ebitda | -6.77 - | -2.14 68.37% | -0.35 83.80% | -2.15 519.46% | ||
ev to operating cash flow | -10.97 - | -3.22 70.61% | -0.42 87.12% | -3.05 633.96% | ||
ev to sales | 6.27 - | |||||
free cash flow per share | -1.56 - | -3.99 156.17% | -2.68 32.88% | -1.28 52.33% | ||
free cash flow yield | -0.09 - | -0.23 156.17% | -0.55 132.38% | -0.15 72.99% | ||
graham net net | -1.52 - | 0.27 117.60% | 3.07 1,044.88% | 4.15 35.27% | ||
graham number | 7.29 - | 21.82 199.14% | 17.68 18.99% | 15.20 14.00% | ||
income quality | 0.63 - | 0.64 0.48% | 0.83 30.06% | 0.60 27.61% | ||
intangibles to total assets | 0.89 - | 0.51 43.07% | 0.32 36.53% | 0.19 40.59% | 0.10 45.73% | |
interest coverage | -486.30 - | -103.36 78.75% | -2.41K 2,230.49% | -25.45 98.94% | ||
interest debt per share | 2.09 - | 0.07 96.66% | 0.01 82.57% | 0.31 2,437.86% | ||
inventory turnover | ||||||
invested capital | 2.16 - | 0.00 99.83% | 0.00 30.04% | 0.05 1,847.86% | ||
market cap | 163.19M - | 163.19M 0% | 132.36M 18.89% | 382.36M 188.88% | ||
net current asset value | -9.93M - | -13.46M 35.61% | 9.23M 168.56% | 89.55M 870.41% | 186.98M 108.80% | |
net debt to ebitda | -0.01 - | 0.70 9,871.13% | 1.19 70.29% | 2.64 122.91% | ||
net income per share | -2.45 - | -6.30 157.09% | -3.23 48.78% | -2.12 34.19% | ||
operating cash flow per share | -1.55 - | -3.98 156.51% | -2.68 32.77% | -1.27 52.36% | ||
payables turnover | ||||||
receivables turnover | 19.12 - | |||||
research and ddevelopement to revenue | 2.70 - | |||||
return on tangible assets | -1.08 - | -1.26 16.42% | -0.79 37.64% | -0.41 47.44% | ||
revenue per share | 0.62 - | |||||
roe | -2.54 - | -1.88 26.14% | -0.75 60.03% | -0.44 41.43% | ||
roic | -0.83 - | -1.78 115.44% | -0.74 58.18% | -0.36 51.65% | ||
sales general and administrative to revenue | 1.24 - | |||||
shareholders equity per share | 0.96 - | 3.36 248.07% | 4.30 28.14% | 4.84 12.37% | ||
stock based compensation to revenue | 0.61 - | |||||
tangible asset value | -9.92M - | -12.95M 30.50% | 9.58M 173.97% | 89.95M 839.05% | 187.22M 108.13% | |
tangible book value per share | -1.35 - | 1.00 173.97% | 3.34 234.41% | 4.24 27.15% | ||
working capital | 2.00M - | -11.37M 669.92% | 12.79M 212.48% | 92.90M 626.38% | 201.47M 116.87% |
All numbers in USD (except ratios and percentages)